Analytica Acta Market Analysis and Reports | USA Conference Series

Market Analysis - Analytica Acta 2017

 

Pharmaceutical Hyphenated Techniques (PHT) plays an important role in both the development process and GMP manufacturing. Concerns about drug safety, costly development programs, complex manufacturing, market demands for evidence-based data and increased regulatory requirements are all issues that can be addressed through a better understanding of your drug substance, drug product or manufacturing process which, in turn, can only be achieved through experienced analytical studies and robust analytical data.


The global life science instrumentation market is projected to reach USD 64.52 Billion by 2021, at a CAGR of 6.8% in the forecast period (2016-2021). Factors such as technological advancements in analytical instruments, rising government spending on pharmaceutical R&D, increasing public and private life science R&D expenditure, growing food safety concerns, and progressing drug discovery and clinical diagnostics are driving the growth of the life science instrumentation market during the forecast period. Moreover, the growing proteomics market and increasing demand of analytical instruments from various industries are offering growth opportunities for market players. However, high cost of instruments, presence of alternative technologies, and dearth of skilled professionals are some of the key factors hampering the growth of this market.


Emerging markets, including India, China, Singapore, and Brazil, have become attractive destinations for companies engaged in the development and marketing of life science instrumentation products. Rising R&D activities by big pharmaceutical and biotechnology companies, increased government investments towards the development of the pharmaceutical industry and growing number of CROs and research laboratories in developing nations are the key factors propelling the demand for life science instruments in the emerging markets.

 

 

As of 2016, Thermo Fisher Scientific, Inc. held the leadership position in the global life science instrumentation market. Over the past three years, the company adopted product launches and enhancements as its key business strategy to ensure its market dominance. Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), and Shimadzu Corporation (Japan) are other key players in this market.

 

Stakeholders

·      Life science instrumentation manufacturers, suppliers, and providers

·      Pharmaceutical & biotechnology companies and CROs

·      Academic institutions and private research institutions

·      Environmental testing laboratories

·      Food and beverage testing centers

·      Hospitals and diagnostic centers

·      Service laboratories

 

The United States is the largest market for pharmaceuticals (including biopharmaceuticals), accounting for around 35 percent of the global market, and is the world leader in biopharmaceutical research and development (R&D). According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct the majority of the world's research and development in pharmaceuticals and hold the intellectual property rights on most new medicines. The biopharmaceutical pipeline also has over 7,000 new medicines currently in development around the world with approximately 3,500 compounds currently being studied in the United States - more than any other region around the world. The National Science Foundation reports that the U.S. biopharmaceutical sector accounts for the largest single share of all U.S. business research and development (R&D) investment, representing 23.4 percent of all domestic R&D funded by U.S. business in 2013.

More than 854,000 people work in the biopharmaceutical industry in the United States across a broad range of occupations, such as scientific research, technical support and manufacturing. Directly and indirectly, the industry supports a total of 4.4 million jobs across the United States and added an estimated $1.2 trillion in economic output in 2014, representing 3.8 percent of total U.S. output. The biopharmaceutical industry provides average salaries well above the average for all U.S. workers, and requires a highly-skilled and educated workforce from the administrative level up to and including Ph.D. scientists.  

The global pharmaceutical market accounted for $4,948.3 million revenue in 2015, and it is expected to grow at a CAGR of 8.1% during 2016-2022. The hybrid mass spectrometry segment accounted for largest share in the global mass spectrometry market in 2015; whereas, among the various end-users, the pharmaceuticals segment accounted for the highest share in the global market in the same year. The global mass spectrometry market is witnessing high growth rate, due to the growing food safety concerns, increasing healthcare expenditure, and technological advancements in mass spectrometers. Also, the new International GMP and GDP certification for pharmaceutical excipients is further propelling the growth of the global mass spectrometry market.

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analysing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

 

Highlights of the report:

 

·      A complete backdrop analysis, which includes an assessment of the parent market

·      Important changes in market dynamics

·      Market segmentation up to the second or third level

·      Historical, current, and projected size of the market from the standpoint of both value and volume

·      Reporting and evaluation of recent industry developments

·      Market shares and strategies of key players

·      Emerging niche segments and regional markets

·      An objective assessment of the trajectory of the market

·      Recommendations to companies for strengthening their foothold in the market

 

 

 

Global Life Science Instrumentation Market, by Technology

 

 

Global Life Science Instrumentation Market, by End User

Cell Counting

Automated Cell Counters

Hemocytometers and Manual Cell Counters

Centrifuges

Microcentrifuges

Multipurpose Centrifuges

Floor-standing Centrifuges

Ultracentrifuges

Chromatography

Liquid Chromatography

Gas Chromatography

Supercritical Fluid Chromatography (SFC) Systems

Thin-layer Chromatography (TLC) Systems

Electrophoresis

Gel Electrophoresis

Capillary Electrophoresis

Flow Cytometry

Cell-based Flow Cytometry

Bead-based Flow Cytometry

Immunoassays

Liquid Handling and Robotics

Automated Liquid Handling

Manual Liquid Handling

Robotic Arms

Track Robot Systems

Microscopy

Optical Microscopy

Electron Microscopy

Confocal Microscopy

Scanning Probe Microscopy

Next-generation Sequencing (NGS)

NGS Platforms

PCR

qPCR

dPCR

Spectroscopy

Molecular Spectroscopy

Atomic Spectroscopy

Mass Spectrometry

Western Blotting

Manual Instruments

Semi-automated Instruments

Automated Instruments

Other Instruments

Heat Sterilization

Moist Heat Sterilization (Autoclaves)

Dry Heat Sterilization

Colorimeters

Fume Hoods

Incubators

Laboratory Balances

Microplate Systems

Microplate Readers

Microplate Washers

Microplate Dispensers

Laboratory Freezers

Freezers

Refrigerators

Cryopreservation Systems

 

Cell Counting

Research Institutions

Hospitals and Diagnostic Laboratories

Pharmaceutical and Biotechnology Companies

Other End Users (Food & Beverage Companies, CROs, and Environmental Testing Companies)

Centrifuges

Hospitals

Biotechnology and Pharmaceutical Companies

Academic and Research Institutes

Chromatography

Pharmaceutical Companies and CROs

Biotechnology and Biopharmaceutical Companies

Academics Research Institutions

Agriculture and Food Industry

Environmental Testing

Other End Users (Government Agencies, Hospitals & Clinics, Cosmetic Industry, and Forensic Laboratories)

Electrophoresis

Academic Institutions

Hospitals and Diagnostic Centers

Pharmaceutical and Biotechnology Companies

Research Organizations

Flow Cytometry

Pharmaceutical and Biotechnology Companies

Medical Schools and Academic Institutions

Hospitals

Research Institutions

Clinical Testing Laboratories

Immunoassay

Hospitals

Clinical Laboratories

Blood Banks

Academic Research Centers

Pharmaceutical & Biotechnology Companies and CROs

Other End Users (Physicians, Home Health Agencies, Nursing Homes, and Ambulatory Surgical Centers)

Liquid Handling and Robotics

Biotechnology and Pharmaceutical Industries

Hospitals and Private Laboratories

Academic Institutes

Research Institutes

Microscopy

Academic Institutes

Industries (Pharmaceutical and Biotechnology, Semiconductor, Textile, Mining, and Oil & Gas)

Other End Users (Government Research Institutions and Private Laboratories)

NGS

Research Centers and Academic & Government Institutes

Hospitals & Clinics

Pharmaceutical and Biotechnology Companies

Other End Users (Non-profit Organizations (NPOs), Agrigenomics Organizations, Laboratories, and Consumer Genomic Companies)

PCR

Research Laboratories and Academic Institutes

Pharmaceutical and Biotechnology Companies

Clinical Research Organizations (CROs)

Forensic Laboratories

Hospitals and Diagnostic Centers

Spectroscopy

Pharmaceutical & Biotechnology Companies and CROs

Environmental Testing

Food and Beverage Testing

Industrial Chemistry

Academic Institutions

Other End Users (Agrochemical Industry, Forensic Laboratories, Biomonitoring Industry, Cosmetics Industry, and Government Agencies)

Western Blotting

Research Institutes

Pharmaceutical and Biotechnology Companies

Diagnostic Laboratories

Other Instruments

Pharmaceutical & Biotechnology Companies and CROs

Research Institutions

Academic Institutions

Other End Users (Diagnostic Laboratories)


 

Global Life Science Instrumentation Market, by Application

 

Research Applications

Clinical and Diagnostic Applications

Other Applications (Industrial Chemistry, Food & Beverage Testing, Environment Testing, Forensic Applications, Cosmetic Industry, and Petrochemical Industry)

Global Life Science Instrumentation Market, by Region

 

North America

Europe

Asia-Pacific

Rest of the World (RoW)